Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma
Protocol ID
ANBL1232
Disease (Sub Disease)
Ganglioneuroblastoma
Neuroblastoma
Neuroblastoma
Diagnosis Stage
Relapse/refractory
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
Trial Status
Closed to Recruitment
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 18 months
International registry ID's
NCT02176967
| Study Title | Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma |
|---|---|
| Protocol ID | ANBL1232 |
| Disease (Sub Disease) | Ganglioneuroblastoma Neuroblastoma |
| Diagnosis Stage | Relapse/refractory |
| Sponsor | Children's Oncology Group |
| Collaborators | National Cancer Institute (NCI) |
| Links | https://clinicaltrials.gov/ct2/show/NCT02176967 |
| Trial Status | Closed to Recruitment |
| Trial Open Date | 28/07/2014 |
| Study Type | Treatment |
| Phase | Phase 3 |
| Age Eligibility | up to 18 months |
| International registry ID's | NCT02176967 |